Skip to main content
NPJ Vaccines logoLink to NPJ Vaccines
. 2021 May 4;6:68. doi: 10.1038/s41541-021-00332-5

Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer

Janos L Tanyi 1,#, Cheryl L-L Chiang 2,✉,#, Johanna Chiffelle 2, Anne-Christine Thierry 3, Petra Baumgartener 3, Florian Huber 2, Christine Goepfert 4,5, David Tarussio 3, Stephanie Tissot 3, Drew A Torigian 6, Harvey L Nisenbaum 6, Brian J Stevenson 2, Hajer Fritah Guiren 2, Ritaparna Ahmed 2, Anne-Laure Huguenin-Bergenat 2, Emese Zsiros 1, Michal Bassani-Sternberg 2, Rosemarie Mick 7, Daniel J Powell Jr 1, George Coukos 2, Alexandre Harari 2,3, Lana E Kandalaft 2,3,
PMCID: PMC8096937  PMID: 33947868

Correction to: npj Vaccines 10.1038/s41541-021-00297-5, published online 15 March 2021

The original version of the published Article contained an error in the Figure legend of Figure 4. This has been corrected in the HTML and PDF version of the Article.

Contributor Information

Cheryl L.-L. Chiang, Email: Lai-Lai-Cheryl.Chiang@chuv.ch

Lana E. Kandalaft, Email: Lana.Kandalaft@chuv.ch


Articles from NPJ Vaccines are provided here courtesy of Nature Publishing Group

RESOURCES